Literature DB >> 28625394

Sentinel node mapping in endometrial cancer following Hysteroscopic injection of tracers: A single center evaluation over 200 cases.

Fabio Martinelli1, Antonino Ditto2, Mauro Signorelli2, Giorgio Bogani2, Valentina Chiappa2, Domenica Lorusso2, Cono Scaffa2, Dario Recalcati2, Stefania Perotto2, Edward Haeusler3, Francesco Raspagliesi2.   

Abstract

OBJECTIVES: To analyze detection-rate(DR) and diagnostic-accuracy (A) of sentinel-nodes(SLNs) mapping following hysteroscopic-injection of tracer. To compare DR and A between tracers: ICG and Tc99m.
METHODS: Evaluation of endometrial-cancer patients who underwent SLNs mapping after hysteroscopic-peritumoral-injection of tracer±lymphadenectomy. Analysis of DR (overall-bilateral-aortic) and A in the entire cohort and comparison between tracers.
RESULTS: 202 procedures were performed from January/2005 to February/2017. Mean age:60years (28-82); mean BMI: 26.8 kg/m2 (15-47). In 133 cases (65.8%) hysterectomy and mapping procedure were performed laparoscopically. The overall-DR of the technique was 93.2% (179/192) (10 cases were excluded: 9 for technical-equipment failure; 1 for vagal reaction). Bilateral pelvic mapping was found in 59.7% of cases (107/179) and was more frequent in the ICG group (72.8% vs 53.3%; p: 0.012). In 50.8% of cases (91/179) SLNs were mapped both in pelvic and aortic nodes, and in 5 cases (2.8%) only in the aortic area. The mean number of detected SLNs was 3.7 (1-8). 22 patients (12.3%) had nodal involvement: 10-(45.5%)-macrometastases; 5-(22.7%)-micrometastases; 7-(31.8%)-ITCs. In 6 cases (27.3%) only aortic nodes were positive; in 5 cases (22.7%) both pelvic and aortic nodes and in 11 cases (50%) only pelvic nodes were involved. Three false-negative results were found, all in the Tc99m group. All had isolated aortic metastases with negative pelvic nodes. Overall-sensitivity was 86.4% (95%CI: 68.4-100) and overall-negative-predictive-value (NPV) was 96.4% (95%CI 86.7-100). No differences in terms of overall-DR, overall-sensitivity and overall-NPV were found between the two tracers.
CONCLUSIONS: Hysteroscopic-injection of tracer for SLNs mapping in endometrial cancer is as accurate as cervical injection with a higher DR in the aortic area. ICG improves bilateral-DR. Further investigation is warranted on this topic.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aortic nodes; Diagnostic accuracy; Endometrial cancer; Hysteroscopy; Indocyanine green/Tc99m; Sentinel node

Mesh:

Substances:

Year:  2017        PMID: 28625394     DOI: 10.1016/j.ygyno.2017.06.014

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

1.  ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

Authors:  Nicole Concin; Carien L Creutzberg; Ignace Vergote; David Cibula; Mansoor Raza Mirza; Simone Marnitz; Jonathan A Ledermann; Tjalling Bosse; Cyrus Chargari; Anna Fagotti; Christina Fotopoulou; Antonio González-Martín; Sigurd F Lax; Domenica Lorusso; Christian Marth; Philippe Morice; Remi A Nout; Dearbhaile E O'Donnell; Denis Querleu; Maria Rosaria Raspollini; Jalid Sehouli; Alina E Sturdza; Alexandra Taylor; Anneke M Westermann; Pauline Wimberger; Nicoletta Colombo; François Planchamp; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2021-02       Impact factor: 4.064

2.  A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes?

Authors:  Lei Ye; ShuangDi Li; Wen Lu; QiZhi He; YiRan Li; BiLan Li; XiaoJun Wang; Qin Yan; XiaoPing Wan
Journal:  Oncologist       Date:  2019-07-03

3.  Paraaortic sentinel lymph node detection in intermediate and high-risk endometrial cancer by transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR).

Authors:  Martina Aida Angeles; Federico Migliorelli; Sergi Vidal-Sicart; Adela Saco; Jaume Ordi; Cristina Ros; Pere Fusté; Meritxell Munmany; Sílvia Escura; Núria Carreras; Nuria Sánchez-Izquierdo; Jaume Pahisa; Aureli Torné; Pilar Paredes; Marta Del Pino
Journal:  J Gynecol Oncol       Date:  2021-03-20       Impact factor: 4.401

4.  Sentinel lymph node biopsy in high-risk endometrial cancer: performance, outcomes, and future avenues.

Authors:  Yoo-Na Kim; Young Tae Kim
Journal:  Obstet Gynecol Sci       Date:  2022-08-02

5.  Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.

Authors:  Hans Nagar; Nina Wietek; Richard J Goodall; Will Hughes; Mia Schmidt-Hansen; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2021-06-09

6.  Role of Indocyanine Green in Fluorescence Imaging with Near-Infrared Light to Identify Sentinel Lymph Nodes, Lymphatic Vessels and Pathways Prior to Surgery - A Critical Evaluation of Options.

Authors:  Andreas Hackethal; Markus Hirschburger; Sven Oliver Eicker; Thomas Mücke; Christoph Lindner; Olaf Buchweitz
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-01-22       Impact factor: 2.915

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.